QLGN Qualigen Therapeutics, Inc.

Nasdaq qualigeninc.com


$ 3.78 $ -0.23 (-5.81 %)    

Thursday, 16-Oct-2025 18:48:10 EDT
QQQ $ 598.23 $ -2.23 (-0.37 %)
DIA $ 458.84 $ -3.15 (-0.68 %)
SPY $ 658.90 $ -4.53 (-0.68 %)
TLT $ 91.49 $ 0.68 (0.75 %)
GLD $ 401.79 $ 9.06 (2.34 %)
$ 3.73
$ 3.92
$ 3.67 x 250
$ 4.21 x 3
$ 3.73 - $ 4.16
$ 1.61 - $ 10.45
96,627
na
6.32M
$ 1.05
nm
TBD
na
na ($ 0.00)
na
TBD na
How to Read 10-K & 10-Q Reports To View SEC Filing Reports, Please Register or Sign In
# Filing Date Period End Date Type Report Link
1 08-14-2025 06-30-2025 10-Q
2 07-21-2025 03-31-2025 10-Q
3 06-30-2025 12-31-2024 10-K
4 11-14-2024 09-30-2024 10-Q
5 08-14-2024 06-30-2024 10-Q
6 07-02-2024 03-31-2024 10-Q
7 04-08-2024 12-31-2023 10-K
8 11-14-2023 09-30-2023 10-Q
9 08-14-2023 06-30-2023 10-Q
10 05-15-2023 03-31-2023 10-Q
11 05-02-2023 12-31-2022 10-K
12 11-14-2022 09-30-2022 10-Q
13 08-15-2022 06-30-2022 10-Q
14 05-13-2022 03-31-2022 10-Q
15 03-31-2022 12-31-2021 10-K
16 11-15-2021 09-30-2021 10-Q
17 08-16-2021 06-30-2021 10-Q
18 05-14-2021 03-31-2021 10-Q
19 11-12-2020 09-30-2020 10-Q
20 08-14-2020 06-30-2020 10-Q
21 05-01-2020 03-31-2020 10-Q
22 03-31-2020 12-31-2019 10-K
23 11-14-2019 09-30-2019 10-Q
24 08-14-2019 06-30-2019 10-Q
25 05-15-2019 03-31-2019 10-Q
26 04-01-2019 12-31-2018 10-K
27 11-09-2018 09-30-2018 10-Q
28 08-14-2018 06-30-2018 10-Q
29 05-15-2018 03-31-2018 10-Q
30 03-19-2018 12-31-2017 10-K
31 10-31-2017 09-30-2017 10-Q
32 08-07-2017 06-30-2017 10-Q
33 05-09-2017 03-31-2017 10-Q
34 02-27-2017 12-31-2016 10-K
35 11-07-2016 09-30-2016 10-Q
36 08-08-2016 06-30-2016 10-Q
37 05-09-2016 03-31-2016 10-Q
38 03-21-2016 12-31-2015 10-K
39 11-10-2015 09-30-2015 10-Q
40 08-12-2015 06-30-2015 10-Q
Guide for Analyst Ratings To View Analyst Ratings, Please Register or Sign In
# Date Analyst Firm Upside/Downside Price Target Change Rating Change Current Rating

News

OPINIONS

Core News & Articles

Qualigen Therapeutics, Inc. (NASDAQ:QLGN) ("Qualigen" or "the Company") today announced the successful closing ...

Core News & Articles

Gainers PepGen (NASDAQ: PEPG) stock rose 114.3% to $5.7 during Thursday's regular session. The market value of their outst...

Core News & Articles

MBX: 46% | MBX Biosciences shares are trading higher after the company announced that it will provide topline results from its ...

Core News & Articles

LOS ANGELES and CARLSBAD, Sept. 19, 2025 (GLOBE NEWSWIRE) -- Faraday Future Intelligent Electric Inc. (NASDAQ:FFAI) ("Farad...

 reported-on-september-16th-qualigen-therapeutics-files-to-sell-up-to-321m-shares-of-common-stock-for-holders

-SEC Filing

 qualigen-therapeutics-provides-update-on-nasdaq-communications-and-continued-listing-status-company-is-making-every-effort-to-maintain-its-current-nasdaq-listing-and-will-continue-to-take-all-necessary-actions-toward-that-goal-however-there-can-be-no-assurance-that-the-company-will-be-able-to-maintain-compliance-with-nasdaqs-continued-listing-requirement

CARLSBAD, Calif., July 28, 2025 (GLOBE NEWSWIRE) -- Qualigen Therapeutics, Inc. (NASDAQ:QLGN) (the "Company") received ...

 qualigen-announces-45m-private-placement-of-4500-shares-of-series-a-3-preferred-stock-convertible-into-161m-common-shares-at-280-each

Qualigen Therapeutics, Inc. (NASDAQ:QLGN) ("Qualigen" or the "Company"), a life sciences company focused on dev...

CLASS ACTION DEADLINES - JOIN NOW!

NEW CASE INVESTIGATION